Clinical trials
Venous Thromboembolism clinical trials
Below are recruiting venous thromboembolism clinical trials, each written for real people, not researchers. We’re tracking 103 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06480994Recruiting
Testing a new tool to help diagnose blood clots
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
Niort, SartresAges 18 years+ - NCT06861088RecruitingPhase 3
Kinisoquin for preventing blood clots in pancreatic cancer
This trial tests whether an investigational drug called Kinisoquin™ can help prevent blood clots in people with advanced pancreatic cancer who are starting their first chemotherapy. It may be a good option if you are looking for extra protection against clots during treatment.
Ventura, CaliforniaAges 18 years+ - NCT07288632Recruiting
Lung cancer gene test and blood clot risk study
This study looks at whether certain gene profiles in advanced lung cancer affect the risk of blood clots. It may help doctors better understand and prevent clots in people starting new cancer treatment.
Perugia, PerugiaAges 18 years+ - NCT07869615Recruiting
Blood thinners after knee replacement surgery
This study compares two types of blood thinners to prevent blood clots after knee replacement surgery. It will help find which one works better and is safer for patients.
Tunis, Tunis GovernorateAges 18–80 - NCT02219984Recruiting
Survey of adults taking blood thinners in a patient registry
This study builds a registry by asking adults who take blood thinners (anticoagulants) about their experiences. It may help improve care by learning how these medicines are used in real life.
Bologna, BOAges 18 years+ - NCT07863115Recruiting
Preventing blood clots after leg injury with a cast
This study looks at a simple checklist to see who is at risk for blood clots after a leg injury that requires a cast or brace. It also checks how well people follow blood-thinning medication to prevent these clots.
MonastirAges 18 years+ - NCT02156401Recruiting
Study of tests and care to improve clot diagnosis
This study follows adults who may have a blood clot in the lung (pulmonary embolism) or leg (deep vein thrombosis), or who were found to have a clot by chance. It aims to improve how doctors diagnose, manage, and estimate risk, which may lead to better, more tailored care for you.
Mainz, Rhineland-PalatinateAges 18 years+ - NCT07820670Recruiting
Blood thinner choice after cesarean section to prevent blood clots
This study compares two blood-thinner medicines given after a C-section to see which one works better at preventing dangerous blood clots. It may help women who are at higher risk for clots rest easier right after delivery.
HolonAges 18–50 - NCT07805616Recruiting
New risk categories for blood clots in the lungs
This study looks at whether a new way of grouping patients with blood clots in the lungs (pulmonary embolism) can better predict their outcomes. If you join, your health will be tracked for 30 days to see how well this new system works.
IstanbulAges 18 years+ - NCT07786779RecruitingPhase 1
Safety study of an injectable drug in healthy adults
This study tests a new injectable medication to see if it is safe and how the body processes it. It is looking for healthy adults to participate and will monitor for side effects and study how the drug works.
Beijing, Beijing MunicipalityAges 18–55 - NCT03559114RecruitingPhase 3
Preventing blood clots after severe brain injury
This trial tests whether taking an anti–blood clot medicine (dalteparin) and using leg compression can reduce dangerous blood clots after a severe traumatic brain injury. It may help lower the chance of clots forming when people are immobile and at higher risk.
Calgary, AlbertaAges 18 years+ - NCT07654634Enrolling by invitation
Precision blood thinning therapy study
This trial tests personalized blood thinner treatment for people who need long-term anticoagulation for conditions like atrial fibrillation or blood clots. The goal is to find the safest and most effective dose for each patient.
Changsha, HunanAges 8 years+ - NCT07499661Recruiting
Study of blood clots in the lungs with heart failure
This study looks at whether a blood clot in the lungs (pulmonary embolism) is a hidden cause in patients who are hospitalized for acute heart failure. It involves additional imaging tests to find a clot if present, which could change your treatment.
AgenAges 18 years+ - NCT07439991Recruiting
Study of blood clot risks after lung cancer surgery
This study looks at why some people develop blood clots after lung cancer surgery. By tracking your recovery for 30 days, researchers hope to find better ways to predict and prevent clots in the future.
Changchun, JilinAges 18 years+ - NCT05773638Recruiting
Study blood clots and heart disease in adults with Von Willebrand
This study looks at cardiovascular problems and blood-clot events (like deep vein clots or pulmonary embolism) in adults with Von Willebrand disease in western France. It may help doctors better understand who is at risk and how to manage these complications.
AngersAges 18 years+ - NCT06749223Recruiting
Testing a D-dimer blood test for blood clots
This study is testing a new D-dimer blood test (AQT90 FLEX) to see how well it detects blood clots in people who have symptoms but a low to moderate risk. If you join, this test may help rule out dangerous clots more quickly.
ViborgAges 18 years+ - NCT07372716Recruiting
Blood thinner safety during cancer surgery
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
OttawaAges 18 years+ - NCT07328152Recruiting
European health data study for rare diseases
This trial combines health information from European research groups to study rare diseases. It looks at data from people who agreed to participate in these studies, which may help find better ways to diagnose or treat rare conditions.
BrestAges Any age - NCT07303816RecruitingPhase 4
Can statins prevent blood clots in cancer patients?
This trial tests whether a daily statin (rosuvastatin) can help prevent dangerous blood clots in people with advanced cancer who are starting new cancer therapy. It is for those at medium or high risk for clots, based on a simple risk score.
Irvine, CaliforniaAges 18 years+ - NCT07292376Enrolling by invitation
Preventing blood clots in cancer outpatients
This trial is testing a program to help prevent blood clots in people with cancer who are starting a new type of cancer treatment, like chemotherapy or targeted therapy. The goal is to see if better prevention strategies can keep you safe during treatment.
Burlington, VermontAges 18 years+ - NCT06894576Recruiting
Creating a risk score for blood clot recurrence and bleeding in cancer patients
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
Ottawa, OntarioAges 18 years+ - NCT06689241Recruiting
Comparing blood thinners to prevent clots after weight-loss surgery
This study compares two blood-thinning medications, rivaroxaban (a pill) and enoxaparin (a shot), to prevent dangerous blood clots after weight-loss surgery. If you are scheduled for bariatric surgery, this trial could help determine which approach works better for someone like you.
AlexandriaAges 20–60 - NCT07189897RecruitingPhase 4
Apixaban vs. Enoxaparin for Blood Clot Prevention After Head and Neck Cancer Surgery
This study compares two blood-thinning medicines (apixaban pills vs. enoxaparin injections) to see which works better at preventing blood clots after head and neck cancer surgery. It may help you avoid dangerous clots without increasing bleeding risk.
Syracuse, New YorkAges 18–89 - NCT07160686RecruitingPhase 3
Blood thinner trial for lung cancer patients on treatment
This trial tests if apixaban, a blood thinner pill, can prevent dangerous blood clots in people with advanced lung cancer who are receiving outpatient chemotherapy or other systemic treatments. It aims to reduce the risk of venous thromboembolism (blood clots in veins) during cancer therapy.
DorchesterAges 16 years+
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for venous thromboembolism?
- Yes. Clin2 currently lists 103 recruiting venous thromboembolism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a venous thromboembolism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a venous thromboembolism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.